Prevalence of raised Alanine Amino transaminase (ALT) in pregnant mothers: A Cross-sectional Study

  • Tabinda Khalid Rawalpindi medical University
  • Rubaba Abid Naqvi
  • Nisar Ahmed Malik
  • Hamna Sarwar
Keywords: Liver dysfunction, pre-eclampsia, acute fatty liver of pregnancy, cholestasis of pregnancy.


bjective: To determine the prevalence of raised ALT, common causes, and associated fetomaternal morbidity  in pregnant mothers presenting, at cantonment general hospital Rawalpindi

Materials and Methods: This was a cross-sectional study conducted at cantonment general hospital Rawalpindi from July 2016 till June 2017.

Results: Out of 1924 women, 102 were identified with raised ALT making a prevalence of 5.3%. Sixty-one (59.8%) were booked. The hypertensive group which included severe preeclampsia, chronic hypertension with superimposed preeclampsia/eclampsia were 55(53.9%), intrahepatic cholestasis of pregnancy(ICP) 32(31.7%), acute viral hepatitis 9(8.8%), Acute fatty liver of pregnancy(AFLP) 2(1.96%), and unknown cause in 4(3.92%).

Mean ALT levels were 54.1±6.94, 71.28±23.25, 84.22±27.82, 231.5±47.37 respectively. In four cases no definitive cause could be identified with the available tests were labeled as an unknown group, having a mean ALT level of 79.25±10.07. (p=0.01).

Term delivery occurred in 71(69.6%), while 31(30.39%) were preterm. There was one termination of pregnancy. Vaginal birth occurred in 42(42.2%), and 53(51.9%) underwent emergency cesarean. There was one peripartum hysterectomy. Meconium stain of liquor was 19(18.6%). The birth weight of most babies 73(71.5%) was between 2-3 kilograms only three were ≤ 1 kilograms.

Eight cases of postpartum hemorrhage, three maternal deaths, and six perinatal/early neonatal deaths were observed.

Conclusion: Raised ALT in pregnancy leads to increased fetomaternal complications. Severe preeclampsia and obstetric cholestasis were the commonest causes. Women of younger age groups were having acute viral hepatitis. Timely recognition and diagnosis are essential to institute appropriate management strategies.


1. Ma K, Berger D, Reau N. Liver diseases during pregnancy. Clinc Liver Dis 2019 May; 23(2):345-361. DOI:10.1016/j.cld.2018.12.013.
Epub 2019 Feb 26.
2. Zhou DX, Bian XY, Cheng XY, Xu P, Zhang YF, Zhong JX, et al. Late gestational liver dysfunction and its impact on pregnancy outcomes. СНn ExpОbstet Gynecol. 2016 Jan 1;43(3):417-21. DOI: 10.12891/ceog2130.2016
3. Keskinkılıç B, Engin-Üstün Y, Sanisoğlu S, Şahin Uygur D, Keskin HL, Karaahmetoğlu S, et al. Maternal mortality due to hypertensive disorders in pregnancy, childbirth, and the puerperium between 2012 and 2015 in Turkey: A nation-based study. J Turk Ger Gynecol Assoc. 2017 Mar 15;18(1):20-25. DOI: 10.4274/jtgga.2016.0244. PMID: 28506946; PMCID: PMC5450206..
4. Vasquez DN, Plante L, Basualdo MN, Plotnikow GG. Obstetric Disorders in the ICU. InSeminars in respiratory and critical care medicine 2017 Apr (Vol. 38, No. 02, pp. 218-234). Thieme Medical Publishers. DOI: 10.1055/s-0037-1600910
5. Yogi L, Tan G, Chengming S, Xuri S. The ICU is Becoming a Main Battlefield for Severe Maternal Rescue in China: An 8- year Single-Centre Clinical Experience. Crit Care Med.2017 Jul26.
DOI: 10.1097/CCM.
6. Munazza B, Raza N, Naureen A, Khan SA, Fatima F, Ayub M, et al. Liver function tests in preeclampsia. J Ayub Med Coll Abbottabad. 2011 Oct-Dec;23(4):3-5. PMID: 23472397.
7. Gedik E, Yücel N, Sahin T, Koca E, Colak YZ, Togal T. Hemolysis, elevated liver enzymes, and low platelet syndrome: Outcomes for patients admitted to Intensive Care at a tertiary referral hospital. Hypertension in pregnancy. 2017 Jan 2;36(1):21-9. DOI:
8. Hafeez M, Ansari A, Parveen S, Salamat A, Aijaz A. Frequency of intrahepatic cholestasis of pregnancy in Punjab Pakistan: A single centre study. J Pak Med Assoc. 2016 Feb 1;66(2):203-6.
9. Sultana R, Sarwar I, Fawad A, Noor S, Bashir R. Neonatal outcome in obstetric cholestasis patients at Ayub Teaching Hospital Abbottabad. Journal of Ayub Medical College Abbottabad. 2009 Dec 1;21(4):76-8.
10. Joutsiniemi T, Timonen S, Linden M, Suvitie P, Ekblad U. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid. BMC gastroenterology. 2015 Dec 1;15(1):92.
11. Parízek A, Simják P, Cerný A, Sestinová A, Zdenková A, Hill M, et al. Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Annals of hepatology. 2017 Jan 15;15(5):757-61. DOI:
12. Friberg AK, ZingmarkY, Lyndrup J. Early induction of labor in High- risk Intrahepatic cholestasis of pregnancy: What are the costs? Arch Gynecol Obstet 2016 Oct;294(4):709-14. DOI:
13. Benova L, Awad SF, Abu Raddad LJ. Estimate of vertical transmission of Hepatitis C in Pakistan in 2007 and 2012 birth cohorts. J Viral Hepat. 2017 Jun29. DOI: 10.1111/jvh.12748.
14. Brohi ZP, Sadaf A, Perveen U. Etiology, clinical features and outcome of fulminant hepatic failure in pregnancy. Age (years). 2013 Sep 15;29(8.404):17-42.
15. Chang CY, Aziz N, Poongkunran M, Javaid A, Trinh HN, Lau D, Nguyen MH. Serum alanine aminotransferase and hepatitis B DNA flares in pregnant and postpartum women with chronic hepatitis B. American Journal of Gastroenterology. 2016 Oct 1;111(10):1410-5. DOI: 10.1038/ajg.2016.296.
16. Jena P, Sheela CN, Venkatachala RP, Devarbhavi H. Obstetric outcome in women with chronic liver disease. The Journal of Obstetrics and Gynecology of India. 2017 Aug 1;67(4):263-9. DOI:
17. Anon B, Barbet C, Gendrot C, Labarthe F, Bacq Y. Acute fatty liver of pregnancy and mitochondrial fatty acid oxidation. Consequences for the offspring. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie. 2017 Jun 21;24(8):777-82. DOI: 10.1016/j.arcped.2017.05.012
18. Liu G, Shang X, Yuan B, Han C, Wang Y. Acute Fatty Liver of Pregnancy: Analysis on the Diagnosis and Treatment of 15 Cases. The Journal of reproductive medicine. 2016;61(5-6):282.
19. Mondal BR, Ahmed S, Saha S, Perveen SI, Paul D, Sultana T, et al. Alanine Aminotransferase and Total Bilirubin Concentration in Preeclampsia and Eclampsia. Mymensingh Med J. 2016 Jan;25(1) 85-90. PMID: 26931255.
20. Kozic JR, Benton SJ, Hutcheon JA, Payne BA, Magee LA, von Dadelszen P. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. Journal of Obstetrics and Gynaecology Canada. 2011 Oct 1;33(10):995-1004. DOI:
21. Mei-Dan E, Wiznitzer A, Sergienko R, Hallak M, Sheiner E. Prediction of preeclampsia: liver function tests during the first 20 gestational weeks. The Journal of Maternal-Fetal & Neonatal Medicine. 2013 Feb 1;26(3):250-3. DOI:
22. Türkmen GG, Timur H, Yilmaz Z, Kirbas A, Daglar K, Tokmak A, et al. Effect of intrahepatic cholestasis of pregnancy on maternal serum screening tests. Journal of neonatal-perinatal medicine. 2016 Jan 1;9(4):411-5. DOI: 10.3233/NPM-161618.
23. Ekiz A, Kaya B, Avci ME, Polat I, Dikmen S, Yildirim G. Alanine aminotransferase as a predictor of adverse perinatal outcomes in women with intrahepatic cholestasis of pregnancy. Pakistan Journal of Medical Sciences. 2016 Mar;32(2):418. DOI: 10.12669/pjms.322.9057.
24. Jurate K, Rimantas Z, Jolanta S, Vladas G, Limas K. Sensitivity and specificity of biochemical tests for diagnosis of intrahepatic cholestasis of pregnancy. Annals of hepatology. 2017 Nov 6;16(4):569-73.
25. Zhou L, Qi HB, Luo X. Analysis of clinical characteristics and perinatal outcome of early-onset intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi. 2013 Jan;48(1):20.
How to Cite
Khalid T, Naqvi R, Malik N, Sarwar H. Prevalence of raised Alanine Amino transaminase (ALT) in pregnant mothers: A Cross-sectional Study. JRMC [Internet]. 30Sep.2020 [cited 2Oct.2022];24(3):187-92. Available from: